Median Duration of Response Not Reached after 25 Months Follow Up. Lifileucel Launch in Previously Treated Advanced NSCLC Expected in Second Half of ...
- Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to have dosed 30 participants in total by early 2026, then plans to meet with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback